NeuroBrave is a technology company.
NeuroBrave has raised $2.0M across 1 funding round.
NeuroBrave has raised $2.0M in total across 1 funding round.
NeuroBrave has raised $2.0M in total across 1 funding round.
NeuroBrave's investors include VentureIsrael.
NeuroBrave is an Israeli startup developing NeuroSpeed OS™, a hardware-agnostic SaaS platform that uses signal processing, deep learning, and generative AI to convert data from everyday wearable devices and biosensors into real-time insights on cognitive and emotional states, such as stress, anxiety, focus, fatigue, and engagement.[1][2][4] It serves individuals seeking mental wellness, healthcare providers, and industries like manufacturing, gaming, fitness, and workplace safety, solving the problem of inaccessible, personalized mental health monitoring by making scientifically validated neurotechnology insights available through commodity devices.[1][2][4] The company has secured funding, including a round backed by VentureIsrael, and partnerships like one with STMicroelectronics for integration with their ST1VAFE3BX sensors and another with Tel Aviv Sourasky Medical Center for brain-computer interfaces (BCI) enabling paralyzed patients to communicate and control devices.[1][3]
NeuroBrave was founded by a team of experienced entrepreneurs, business managers, and tech experts skilled in deep learning, signal processing, data science, and cloud technologies, based in Beer Sheva, Israel (with some records noting Jerusalem).[1][2][3] The idea emerged amid the exponential progress in technology and neuroscience, particularly the shift to commercial neurotechnologies using biosignals from wearables, aiming to responsibly turn these signals into actionable insights for better self-understanding, productivity, and well-being.[2] Early traction includes a funding round from deep tech fund VentureIsrael, a partnership with STMicroelectronics to integrate NeuroSpeed OS™ with their hardware, and a research-commercial collaboration with Tel Aviv Sourasky Medical Center to advance generative AI in BCI for real-time thought translation.[1][3]
NeuroBrave rides the neurotechnology wave, where biosignals from wearables become commoditized amid advances in AI and neuroscience, enabling consumer and enterprise applications for mental health and human performance.[2] Timing aligns with post-2020 surges in remote wellness tech, BCI innovations, and generative AI, amplified by partnerships like STMicroelectronics for edge AI hardware and hospital trials for paralyzed patient communication.[1][3] Market forces favoring it include rising demand for non-invasive mental health tools, workplace productivity analytics, and ethical neurotech amid privacy concerns, influencing the ecosystem by democratizing insights via SaaS to lower barriers for developers and industries.[2][4]
NeuroBrave is poised to expand NeuroSpeed OS™ into more BCI and enterprise verticals, leveraging funding momentum and partnerships to scale real-time neuro-insights globally.[3] Trends like ubiquitous wearables, edge AI, and personalized medicine will propel growth, potentially evolving its influence from wellness startup to core enabler in neurotech ecosystems, responsibly bridging signals to self-awareness for a healthier future.[1][2] This positions it at the forefront of turning everyday data into transformative human insights.
NeuroBrave has raised $2.0M across 1 funding round. Most recently, it raised $2.0M Seed in March 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Mar 1, 2021 | $2.0M Seed | VentureIsrael |